
FDA expands indications for Wandercraft robotic exoskeleton
Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.

Wandercraft announced today that the FDA expanded the indications for its flagship Atalante X rehabilitation device.

As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that replicates a regenerating liver, offering new hope for future treatments.

A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research Institute of A Coruña (INIBIC), as well as other international research groups, has developed pioneering technology that enables human kidney organoids to be produced in a scalable manner.

Researchers from Singapore General Hospital (SGH) and National University of Singapore (NUS) found that using pulsed electromagnetic fields to stimulate muscle tissue and mimic the effects of exercise could benefit patients with type 2 diabetes with excess belly fat.

Studies showed that the assay demonstrated a 94.90% sensitivity in polymerase chain reaction-confirmed positive samples.

SCOTTSDALE, Ariz., Oct. 30, 2025 /PRNewswire/ — In an exciting breakthrough for eye health, Barnet Dulaney Perkins, a leader in ophthalmic innovation, uses an advanced cataract surgery technique that delivers faster recovery, increased precision, and exceptional long-term results. The approach, which incorporates cutting-edge technology, revolutionizes how cataracts are treated, benefiting millions of patients worldwide.

Around a third of people over the age of 80 suffer from age-related macular degeneration (AMD), with an estimated 20 million Americans aged 40 and older currently living with AMD.

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim X2 insulin pump with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus CGM.

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate diagnoses for heart failure, in both women and men.

Australian scientists have developed a biosensor that can rapidly detect the heart failure biomarker S100A7 in saliva, offering a simple, noninvasive way to identify the disease. The breakthrough, published in Biosensors and Bioelectronics: X, could make heart failure screening more accessible, especially in remote and under-resourced communities.